N‐methyl‐d‐aspartate receptor antibody encephalitis: how much treatment is enough?

E-ISSN： 1469-8749|57|1|14-15

ISSN： 0012-1622

Source： DEVELOPMENTAL MEDICINE & CHILD NEUROLOGY, Vol.57, Iss.1, 2015-01, pp. : 14-15

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Intrathecal treatment of anti‐N‐Methyl‐d‐aspartate receptor encephalitis in children

DEVELOPMENTAL MEDICINE & CHILD NEUROLOGY, Vol. 57, Iss. 1, 2015-01 ,pp. : 95-99

John Wiley & Sons Inc

Access to resources Recommend Favorite

Intravenous methylprednisolone versus therapeutic plasma exchange for treatment of anti‐n‐methyl‐d‐aspartate receptor antibody encephalitis: A retrospective review

JOURNAL OF CLINICAL APHERESIS, Vol. 30, Iss. 4, 2015-08 ,pp. : 212-216

John Wiley & Sons Inc

Access to resources Recommend Favorite

What is the evidence to support the use of plasma exchange as first‐line therapy for N‐methyl d‐aspartate receptor antibody encephalitis?

JOURNAL OF CLINICAL APHERESIS, Vol. 33, Iss. 1, 2018-02 ,pp. : 126-127

John Wiley & Sons Inc

Access to resources Recommend Favorite

N‐methyl‐d‐aspartate (NMDA) receptor antibodies encephalitis mimicking an autistic regression

DEVELOPMENTAL MEDICINE & CHILD NEUROLOGY, Vol. 58, Iss. 10, 2016-10 ,pp. : 1092-1094

John Wiley & Sons Inc

Access to resources Recommend Favorite

Anti–N‐methyl‐D‐aspartate receptor encephalitis with multiphasic demyelination

ANNALS OF NEUROLOGY, Vol. 76, Iss. 3, 2014-09 ,pp. : 462-464

John Wiley & Sons Inc

Access to resources Recommend Favorite